Across TCGA pan-cancer cohorts, EIF3MP1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of EIF3MP1’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where EIF3MP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EIF3MP1 is over-expressed in tumor.
COAD, THCA, and STAD are the cancer types where EIF3MP1 tumor–normal differential expression is most reproducible.